Acquisition Compliments Teleflex’s Existing ARROW Vascular
Positioning System (VPS) to now include familiar ECG-only technology for
the elimination of chest X-ray.
Additionally, an alternative system with novel navigation
capability is under development.
WAYNE, Pa.--(BUSINESS WIRE)--Jan. 11, 2016--
Teleflex Incorporated (NYSE:TFX), a leading global provider of medical
devices for critical care and surgery, has acquired privately held
Nostix, LLC, a Boulder, Colorado developer of innovative tip
confirmation systems that are used to increase the accuracy of vascular
access device placement. Currently, Nostix’s ECG-only system is being
marketed in the United States for use in placement of peripherally
inserted central catheters (PICC) and is used as an alternative to X-ray
confirmation in adult patients.
“Adding the Nostix product line provides our customers with the ability
to implement catheter tip placement solutions that meet their specific
therapeutic and budget needs,” said Benson Smith, Chairman, President
and CEO of Teleflex. “The ECG-only product and the range of navigation
technologies that are under development will complement our ARROW VPS G4
system by diversifying and strengthening our PICC tip confirmation and
navigation portfolio and enhance our ability to meet customer needs
globally. Strategically, the addition of this technology will support
Teleflex’s future expansion into tip confirmation for central venous
catheters, chronic hemodialysis catheters and ports. We also gain access
to an innovative product development pipeline, which includes integrated
ultrasound capabilities that will extend our ability to offer
differentiated catheter tip positioning solutions well into the future.”
The financial terms of the transaction were not disclosed.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to
improve the health and quality of people’s lives. We apply purpose
driven innovation – a relentless pursuit of identifying unmet clinical
needs – to benefit patients and healthcare providers. Our portfolio is
diverse, with solutions in the fields of vascular and interventional
access, surgical, anesthesia, cardiac care, urology, emergency medicine
and respiratory care. Teleflex employees worldwide are united in the
understanding that what we do every day makes a difference. For more
information, please visit www.teleflex.com.
Teleflex is the home of ARROW®, Deknatel®, Hudson
RCI®, LMA®, Pilling®, Rüsch®
and Weck® – trusted brands united by a common sense of
purpose.
About Nostix, LLC
Nostix, LLC is a privately held medical technology company that develops
and commercializes differentiated PICC tip placement confirmation and
navigation products. It was founded in 2001 and is headquartered in
Boulder, Colorado.
JMP Securities LLC served as exclusive financial advisor to Nostix in
the transaction.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
Teleflex, the Teleflex logo, ARROW, Deknatel, Hudson RCI, LMA,
Pilling, Rüsch and Weck are trademarks or registered trademarks of
Teleflex Incorporated or its affiliates, in the U.S. and/or other
countries.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160111005026/en/
Source: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President, Investor Relations
610-948-2836